Test Data Is Part of the Validation Argument

Lukas
By

A test result reflects the conditions under which it was produced. Data selection matters because an easy or unrealistic dataset can make a test pass without addressing the intended behavior.

Define what the data must exercise

Identify normal cases, meaningful boundaries and relevant invalid inputs. A calculation test may need values near rounding or limit conditions. An interface test may need missing fields, unusual characters or duplicate identifiers. Select cases because they address a requirement or risk, rather than because they are easy to generate.

For a hypothetical expiry calculation, a dataset might need month-end and leap-year conditions. The expected outcomes should be established independently of the software being tested. Using the application’s own output as the reference would create a circular assessment.

Control preparation and use

Record the dataset version, preparation method and relevant transformations. If data is copied from another environment, assess whether it is suitable and whether sensitive information requires protection. Synthetic data can be useful, but its limitations should be understood, particularly for unusual real-world combinations.

AI can propose candidate cases or help identify missing boundaries. Reviewers should confirm correctness and relevance before the data becomes part of an approved test. Generated expected results require the same scrutiny as generated input values.

Preserve the execution context

Link the result to the actual input data and any changes made during execution. A dataset name is insufficient if the underlying values can be overwritten without version identification. When a test is repeated, establish whether the same data or a justified alternative was used.

Validfor’s test management can be evaluated for how data conditions remain attached to execution records. Its catalogue’s AI-assisted scenarios and review boundaries make data suitability a natural part of the assessment. The useful outcome is evidence whose operating conditions are clear to the reviewer.

Representative data strengthens the meaning of a result. The team should be able to explain why the chosen cases address the behavior it needs to establish.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article